CURE Program offers first foothold for science careers
By Robert Levy
The poise and self-assurance of the presenters at a research symposium at Dana-Farber made it easy to forget they are students in high school and college.
The August 14-16 event represented a graduation of sorts for the 34 students who participated in this summer’s Continuing Umbrella of Research Experiences (CURE) program of the Dana-Farber/Harvard Cancer Center (DF/HCC). Since its creation in 2002, the program has provided research opportunities in research labs for nearly 250 students from minority groups traditionally underrepresented in biomedical research. By making such experiences available, the program offers the first step on the ladder to a career in cancer and biomedical research.
More than 100 DF/HCC scientists have volunteered to participate in the program, welcoming CURE students into their research environments for the summer and assigning them to specific research projects. The program enables students to immerse themselves in the life and rhythms of a lab – conducting experiments, analyzing results, attending lab meetings, and making presentations under the guidance of a mentor and the lab director.
The experience has proven to be a powerful attraction to a career in biosciences. Fully 87 percent of the program’s graduates are currently on a science career track, either as medical students, graduate students, or working professionals, including several employed at Dana-Farber, says Karen Burns White of Research Administration, the program’s director.
“When we started the program, the research experiences available to students were all in basic science,” Burns White remarks. “Over the years, we’ve added population science, nursing research, clinical research, as well as bioinformatics and computational biology – largely because of scientists in these areas who expressed an interest in joining the program.”
The range of opportunities is evident in the research projects presented by this year’s “class.” They include studies of immune cell activity in stem cell transplant patients treated for graft-versus-host disease; the role of a key enzyme in leukemia; the use of nanoparticles in delivering drugs to prostate tumor cells; the role of circadian rhythm disruption in breast cancer risk, and many others.
The presenters benefited from the presence of CURE students of previous years. “A number of our ‘graduates’ were on hand to meet and talk with this year’s students,” Burns Whites notes. “It’s hard to overstate the impact that seeing someone who has been through the program and gone on to a science career can have.”
For this year’s students as for their predecessors, the summer-long immersion in science has whetted or confirmed an interest in a scientific career. “I’ve wanted to be a physician, but now I’d like to find ways to combine that with research,” said Daniela Bennett, a senior at the University of Massachusetts, Boston, who worked in the lab of Dana-Farber’s Myles Brown, MD.
As valuable as the skills the students have acquired and the analytical abilities they’ve honed are the role models they’ve found in the lab. “This is the first time I’ve worked in a science lab,” said Shelby Jean-Michel, a UMass Lowell student assigned to Sabina Signoretti, MD’s, lab at Brigham and Women’s Hospital. “I’ve gotten to know the people in the lab and see how they work. It’s something I can see myself doing.”